Episode 150: Are There Real Solutions to the ABIM MOC?

Episode 150: Are There Real Solutions to the ABIM MOC?

Join Chadi in a thought-provoking discussion with Bryan Carmody, aka the “Sheriff of Sodium” and a pediatric nephrologist, as they tackle the challenges of the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Bryan shares his visionary solutions to simplify and improve the MOC process, shedding light on the potential benefits for physicians and patients alike. Whether you’re a physician, healthcare professional, or just curious about the future of medical certification, this episode offers insights into a critical issue in modern medicine.

Related Resources

View the Sheriff of Sodium here: https://thesheriffofsodium.com/page/6/

View Dr. Carmody’s YouTube discussions on the matter:

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 223: From Lab to Statup: Dr. Simrit Parmar on Launching Cellenkos

Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous

Read More

Episode 222: Language Matters: A Patient Perspective

Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those

Read More

Episode 221: Major Progress in Adjuvant Renal Cell Carcinoma

Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease

Read More